ScienceDaily (Dec. 25, 2007) - Researchers from the Universities of Warwick, Edinburgh, Dundee and the Czech Republic's Institute of Biophysics have discovered a new light-activated platinum-based compound that is up to 80 times more powerful than other platinum-based anti-cancer drugs and which can use "light activation" to kill cancer cells in much more targeted way than similar treatment
Awada A, Ismael G.
The challenging integration of platinum compounds, taxanes, and molecular-targeted therapies in the multidisciplinary treatment of squamous cell carcinoma of the head and neck.
Curr Opin Oncol. 2007 May;19(3):177-9.
PMID: 17414633 [
Specenier P, Vermorken JB.
The role of taxanes and targeted therapies in locally advanced head and neck cancer.
Curr Opin Oncol. 2007 May;19(3):195-201.
PMID: 17414636 [PubMed - in process]